{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:10:51Z","timestamp":1788293451953,"version":"build-2803163510"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":1878,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) typically undergo frequent clinical evaluation. The incidence and outcomes of coronavirus disease (COVID-19) and its impact on routine management for patients with pulmonary vascular disease is currently unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess the cumulative incidence and outcomes of recognized COVID-19 for patients with PAH\/CTEPH followed at accredited pulmonary hypertension centers, and to evaluate the pandemic's impact on clinic operations at these centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A survey was e-mailed to program directors of centers accredited by the Pulmonary Hypertension Association. Descriptive analyses and linear regression were used to analyze results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventy-seven center directors were successfully e-mailed a survey, and 58 responded (75%). The cumulative incidence of COVID-19 recognized in individuals with PAH\/CTEPH was 2.9 cases per 1,000 patients, similar to the general U.S. population. In patients with PAH\/CTEPH for whom COVID-19 was recognized, 30% were hospitalized and 12% died. These outcomes appear worse than the general population. A large impact on clinic operations was observed including fewer clinic visits and substantially increased use of telehealth. A majority of centers curtailed diagnostic testing and a minority limited new starts of medical therapy. Most centers did not use experimental therapies in patients with PAH\/CTEPH diagnosed with COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The cumulative incidence of COVID-19 recognized in patients with PAH\/CTEPH appears similar to the broader population, although outcomes may be worse. Although the total number of patients with PAH\/CTEPH recognized to have COVID-19 was small, the impact of COVID-19 on broader clinic operations, testing, and treatment was substantial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202005-521oc","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T17:14:00Z","timestamp":1596042840000},"page":"1576-1582","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":54,"title":["A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care"],"prefix":"10.1093","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7715-2107","authenticated-orcid":false,"given":"Joshua D.","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Burger","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Mayo Clinic Florida, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genecelle B.","family":"Delossantos","sequence":"additional","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Grinnan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Virginia Commonwealth University, Richmond, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Ralph","sequence":"additional","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam G.","family":"Rayner","sequence":"additional","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeenat","family":"Safdar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey E.","family":"Ventetuolo","sequence":"additional","affiliation":[{"name":"Department of Medicine and Health Services, Policy and Practice, Brown University, Providence, Rhode Island; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roham T.","family":"Zamanian","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5716-248X","authenticated-orcid":false,"given":"Peter J.","family":"Leary","sequence":"additional","affiliation":[{"name":"Department of Medicine and"},{"name":"Department of Epidemiology, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"2026012203452747000_bib1","first-page":"489","article-title":"Managing the patient with pulmonary hypertension: specialty care centers, coordinated care, and patient support","volume":"34","author":"Chakinala","year":"2016","journal-title":"Cardiol Clin"},{"key":"2026012203452747000_bib2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"2026012203452747000_bib3","article-title":"Coronavirus Disease 2019 (COVID-19)","author":"CDC","year":"2020"},{"key":"2026012203452747000_bib4","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2020.03.021","article-title":"Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from ACC's Interventional Council and SCAI","volume":"75","author":"Welt","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026012203452747000_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2026012203452747000_bib6","first-page":"e35","article-title":"Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"8","author":"Emami","year":"2020","journal-title":"Arch Acad Emerg Med"},{"key":"2026012203452747000_bib7","first-page":"2045894020922799","article-title":"Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?","volume":"10","author":"Horn","year":"2020","journal-title":"Pulm Circ"},{"key":"2026012203452747000_bib8","doi-asserted-by":"crossref","first-page":"2045894020920153","DOI":"10.1177\/2045894020920153","article-title":"Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic","volume":"10","author":"Ryan","year":"2020","journal-title":"Pulm Circ"},{"key":"2026012203452747000_bib9","article-title":"Week 6 survey","author":"Primary Care & COVID-19","year":"2020"},{"key":"2026012203452747000_bib10"},{"key":"2026012203452747000_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.conctc.2015.12.006","article-title":"Self-reported physician practices in pulmonary arterial hypertension: diagnosis, assessment, and referral","volume":"2","author":"Polanco-Briceno","year":"2015","journal-title":"Contemp Clin Trials Commun"},{"key":"2026012203452747000_bib12","article-title":"Coronavirus disease 2019 (COVID-19): Cases in the U.S","author":"CDC","year":"2020"},{"key":"2026012203452747000_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/EDE.0000000000001202","article-title":"Estimating the size of a COVID-19 epidemic from surveillance systems","volume":"31","author":"Yue","year":"2020","journal-title":"Epidemiology"},{"key":"2026012203452747000_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1056\/NEJMp0904380","article-title":"Managing and reducing uncertainty in an emerging influenza pandemic","volume":"361","author":"Lipsitch","year":"2009","journal-title":"N Engl J Med"},{"key":"2026012203452747000_bib15","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/jama.2020.3633","article-title":"Care for critically ill patients with COVID-19","volume":"323","author":"Murthy","year":"2020","journal-title":"JAMA"},{"key":"2026012203452747000_bib16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1473-3099(20)30195-X","article-title":"Real estimates of mortality following COVID-19 infection","volume":"20","author":"Baud","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2026012203452747000_bib17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1473-3099(20)30244-9","article-title":"The many estimates of the COVID-19 case fatality rate","volume":"20","author":"Rajgor","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2026012203452747000_bib18","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15585\/mmwr.mm6915e3","article-title":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, March 1-30, 2020","volume":"69","author":"Garg","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026012203452747000_bib19","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"2026012203452747000_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4683","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","volume-title":"JAMA","author":"Onder"},{"key":"2026012203452747000_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/11592430-000000000-00000","article-title":"Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population","volume":"9","author":"Kirson","year":"2011","journal-title":"Appl Health Econ Health Policy"},{"key":"2026012203452747000_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/11592440-000000000-00000","article-title":"Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population","volume":"9","author":"Kirson","year":"2011","journal-title":"Appl Health Econ Health Policy"},{"key":"2026012203452747000_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/2040622317693218","article-title":"Steps forward in the treatment of pulmonary arterial hypertension: latest developments and clinical opportunities","volume":"8","author":"Badlam","year":"2017","journal-title":"Ther Adv Chronic Dis"},{"key":"2026012203452747000_bib24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jamcollsurg.2020.04.030","article-title":"Implementation guide for rapid integration of an outpatient telemedicine program during the COVID-19 pandemic","volume":"231","author":"Smith","year":"2020","journal-title":"J Am Coll Surg"},{"key":"2026012203452747000_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","volume-title":"JAMA","author":"Sanders"},{"key":"2026012203452747000_bib26","article-title":"Information for clinicians on investigational therapeutics for patients with COVID-19","author":"CDC","year":"2020"},{"key":"2026012203452747000_bib27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.healun.2020.04.007","article-title":"Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: friend or foe?","volume":"39","author":"Badagliacca","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2026012203452747000_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12875-019-0979-7","article-title":"Concordance of care processes between medical records and patient self-administered questionnaires","volume":"20","author":"Khanji","year":"2019","journal-title":"BMC Fam Pract"},{"key":"2026012203452747000_bib29","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1017\/ice.2016.171","article-title":"Research methods in healthcare epidemiology: survey and qualitative research","volume":"37","author":"Safdar","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026012203452747000_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1378\/chest.10-0837","article-title":"International classification of diseases coding changes lead to profound declines in reported idiopathic pulmonary arterial hypertension mortality and hospitalizations: implications for database studies","volume":"139","author":"Link","year":"2011","journal-title":"Chest"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/17\/12\/1576\/66347984\/annalsats_17_12_1576.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/17\/12\/1576\/66347984\/annalsats_17_12_1576.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:50:55Z","timestamp":1769071855000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/17\/12\/1576\/8418669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,1]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202005-521oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2020-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}